NBTXR3 Activated by Radiotherapy in Combination With Nivolumab or Pembrolizumab in Patients With Advanced Cancers: A Phase I TrialColette J. Shen, Tanguy Y. Seiwert, Jessica M. Frakes et al.|International Journal of Radiation Oncology*Biology*Physics|2021Cited by 1
P2.01-013 Nab-Paclitaxel/Carboplatin in Elderly Patients with NSCLC (ABOUND.70+): Analysis of Safety and Quality of Life (QoL) by CycleE. Kim, Corey J. Langer, Jonathan W. Goldman et al.|Journal of Thoracic Oncology|2017Cited by 0